Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Cook

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Nature Communications|November 17, 2025
RAF inhibitors activate the integrated stress response by direct activation of GCN2Rebecca Gilley, Andrew M Kidger, Graham Neill, et al.
Science (New York, N.Y.)|April 23, 2016
RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescenceAlison Galloway, Alexander Saveliev, Sebastian Łukasiak, et al.
Molecular Cell|December 13, 2005
Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cellsBarbara Nicke, Julie Bastien, Sophia J Khanna, et al.
Trends in Molecular Medicine|August 10, 2015
Stimulating translational research: several European life science institutions put their heads togetherMohamed Bentires-Alj, Abinaya Rajan, Wim van Harten, et al.
The Journal of Biological Chemistry|March 4, 2006
Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infectionParjeet K Boughan, Richard H Argent, Mathilde Body-Malapel, et al.
Nature Communications|May 4, 2019
MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAF<sup>V600E</sup> amplification whereas KRAS<sup>G13D</sup> amplification promotes EMT-chemoresistanceMatthew J Sale, Kathryn Balmanno, Jayeta Saxena, et al.
Nature Communications|November 16, 2019
Targeting melanoma's MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitorsMatthew J Sale, Emma Minihane, Noel R Monks, et al.
Journal of Medicinal Chemistry|April 25, 2022
Parallel Optimization of Potency and Pharmacokinetics Leading to the Discovery of a Pyrrole Carboxamide ERK5 Kinase Domain InhibitorDuncan C Miller, Tristan Reuillon, Lauren Molyneux, et al.
European Journal of Medicinal Chemistry|June 19, 2019
Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4Stephanie M Myers, Duncan C Miller, Lauren Molyneux, et al.
Cell|December 24, 2025
Modeling human embryo implantation in vitroMatteo A Molè, Sarah Elderkin, Irene Zorzan, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Nature Communications|November 17, 2025
RAF inhibitors activate the integrated stress response by direct activation of GCN2Rebecca Gilley, Andrew M Kidger, Graham Neill, et al.
Science (New York, N.Y.)|April 23, 2016
RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescenceAlison Galloway, Alexander Saveliev, Sebastian Łukasiak, et al.
Molecular Cell|December 13, 2005
Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cellsBarbara Nicke, Julie Bastien, Sophia J Khanna, et al.
Trends in Molecular Medicine|August 10, 2015
Stimulating translational research: several European life science institutions put their heads togetherMohamed Bentires-Alj, Abinaya Rajan, Wim van Harten, et al.
The Journal of Biological Chemistry|March 4, 2006
Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infectionParjeet K Boughan, Richard H Argent, Mathilde Body-Malapel, et al.
Nature Communications|May 4, 2019
MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAF<sup>V600E</sup> amplification whereas KRAS<sup>G13D</sup> amplification promotes EMT-chemoresistanceMatthew J Sale, Kathryn Balmanno, Jayeta Saxena, et al.
Nature Communications|November 16, 2019
Targeting melanoma's MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitorsMatthew J Sale, Emma Minihane, Noel R Monks, et al.
Journal of Medicinal Chemistry|April 25, 2022
Parallel Optimization of Potency and Pharmacokinetics Leading to the Discovery of a Pyrrole Carboxamide ERK5 Kinase Domain InhibitorDuncan C Miller, Tristan Reuillon, Lauren Molyneux, et al.
European Journal of Medicinal Chemistry|June 19, 2019
Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4Stephanie M Myers, Duncan C Miller, Lauren Molyneux, et al.
Cell|December 24, 2025
Modeling human embryo implantation in vitroMatteo A Molè, Sarah Elderkin, Irene Zorzan, et al.
Pageof 10